ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2015
Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultation.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Nocebo in Biosimilars and Generics in Neurology: A Systematic Review.Frontiers in pharmacology · 2019Pooled it
- Effects of likelihood framing on side effect expectations and nocebo side effects: Results from three experimental studies with a placebo analgesic cream.British journal of health psychology · 2026Article
- COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.Rheumatology international · 2022Article
- Prediction and associated factors of non-steroidal anti-inflammatory drugs efficacy in migraine treatment.Frontiers in pharmacology · 2022Article
- Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers.Vaccines · 2021Article
- Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.Headache · 2021Article
- Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic.Mediterranean journal of rheumatology · 2020Article
- The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice.Mediterranean journal of rheumatology · 2019Review
- Nocebos in rheumatology: emerging concepts and their implications for clinical practice.Nature reviews. Rheumatology · 2018Review
- Patients' preferences for headache acute and preventive treatment.The journal of headache and pain · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nocebo affects significantly adherence and treatment outcome and varies considerably among neurological conditions. We aimed to evaluate a questionnaire to predict nocebo in outpatients seeking neurological consultation. A four-item (rating range 4-20) self-fulfilled questionnaire (Q-No) was given in outpatients seeking neurological consultation at the Athens Naval Hospital. A blind to Q-No scoring neurologist rated outpatients as nocebo or no-nocebo after follow-up of >6 months. 341 (71.5 % females) patients with mean age 46.9 (±13.8) years fulfilled the requested follow-up and Q-No. The mean total score was 13.2 (±3.7). The Crombach's alpha coefficient was 0.627. Neurologist suggested 80 patients (23.7 %) as nocebo and 258 as no-nocebo (mean Q-No score = 12.4 95 % CI [12.0-12.9] and 15.8, 95 % CI [15.1-16.6], respectively). Using a cut-off at score 15 the Q-No predicts nocebo with 71.7 % specificity, 67.5 % sensitivity and 42.5 % positive predictive value. Q-No may serve as a useful tool to predict nocebo in outpatients seeking neurological consultation.
Indexed as
Identifiers
25249398What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.